Funded Tech Companies
Pulmocide
Pulmocide is a biopharmaceutical company, located in London. Venture investment and financing was provided by Asahi Kasei, SR One Capital Management and Cystic Fibrosis Foundation.
Company Overview
Company Name
Pulmocide
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
44 Southampton Buildings
London, WC2A 1AP
UK
London, WC2A 1AP
UK
Phone
Website
Email Address
Company Background Information
Overview
Pulmocide is a privately-held company located in London, developing novel small molecule inhaled medicines for the treatment of life threatening respiratory infections caused by RSV and Aspergillus.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/6/2022
Financing History
Management Team
Title
Name
Email & Social
Chairman
Daniel Burgess
Chief Medical Officer
Lance Berman
Chief Scientific Officer
Pete Strong
VP - Bus. Development
Jennifer Cayer
VP - Operations
David Mantus
Company Investors
- Asahi Kasei
- SR One Capital Management
- Cystic Fibrosis Foundation
- Vivo Capital
- Jeito Capital
- Longwood Fund
- IP Group
- F-Prime Capital
- SV Health Investors
- Adjuvant Capital
- Johnson & Johnson Innovation
- Pictet
- SR One Capital Management (Matthew Foy)
- Johnson & Johnson Development Corporation
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs